ClinicalTrials.govpublic full text
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
type 2 diabetes mellitus, overweight and obesity, methionine aminopeptidase 2 inhibitor, diabetes mellitus, type 2, blood glucose, overweight, obesity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870115
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.